CY1107425T1 - Μεθοδος για την παρασκευη παραγωγων 1,4-διφαινυλαζετιδινονης - Google Patents

Μεθοδος για την παρασκευη παραγωγων 1,4-διφαινυλαζετιδινονης

Info

Publication number
CY1107425T1
CY1107425T1 CY20081100037T CY081100037T CY1107425T1 CY 1107425 T1 CY1107425 T1 CY 1107425T1 CY 20081100037 T CY20081100037 T CY 20081100037T CY 081100037 T CY081100037 T CY 081100037T CY 1107425 T1 CY1107425 T1 CY 1107425T1
Authority
CY
Cyprus
Prior art keywords
radicals
aryl
alkyl
diffinylazeidinone
products
Prior art date
Application number
CY20081100037T
Other languages
Greek (el)
English (en)
Inventor
Andreas Lindenschmidt
David William Will
Gerhard Jaehne
Theodor Andreas Wollmann
Wendelin Frick
Bernd Junker
David Rigal
Guenter Billen
Heiner Jendralla
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200410025071 external-priority patent/DE102004025071B4/de
Priority claimed from DE102005010770A external-priority patent/DE102005010770A1/de
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of CY1107425T1 publication Critical patent/CY1107425T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY20081100037T 2004-05-21 2008-01-10 Μεθοδος για την παρασκευη παραγωγων 1,4-διφαινυλαζετιδινονης CY1107425T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE200410025071 DE102004025071B4 (de) 2004-05-21 2004-05-21 Verfahren zur Herstellung von Diphenylazetidinon-Derivaten
DE102005010770A DE102005010770A1 (de) 2005-03-09 2005-03-09 Verfahren zur Herstellung von 1,4-Diphenylazetidinon-Derivaten
EP05747892A EP1756049B1 (de) 2004-05-21 2005-05-20 Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten

Publications (1)

Publication Number Publication Date
CY1107425T1 true CY1107425T1 (el) 2013-03-13

Family

ID=37561403

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100037T CY1107425T1 (el) 2004-05-21 2008-01-10 Μεθοδος για την παρασκευη παραγωγων 1,4-διφαινυλαζετιδινονης

Country Status (25)

Country Link
US (1) US7488818B2 (https=)
EP (1) EP1756049B1 (https=)
JP (1) JP2007538042A (https=)
KR (1) KR20070027554A (https=)
AR (1) AR049184A1 (https=)
AT (1) ATE376997T1 (https=)
AU (1) AU2005245124A1 (https=)
BR (1) BRPI0510150A (https=)
CA (1) CA2567149A1 (https=)
CY (1) CY1107425T1 (https=)
DE (1) DE502005001841D1 (https=)
DK (1) DK1756049T3 (https=)
ES (1) ES2294712T3 (https=)
HR (1) HRP20070570T3 (https=)
IL (1) IL178991A0 (https=)
MA (1) MA28635B1 (https=)
MX (1) MXPA06013456A (https=)
NZ (1) NZ551413A (https=)
PL (1) PL1756049T3 (https=)
PT (1) PT1756049E (https=)
RS (1) RS50539B (https=)
RU (1) RU2380361C2 (https=)
TW (1) TW200611896A (https=)
UY (1) UY28912A1 (https=)
WO (1) WO2005113496A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
CN100471835C (zh) * 2003-12-23 2009-03-25 默克公司 抗高胆固醇血症化合物
EP1699759B1 (en) 2003-12-23 2010-10-20 AstraZeneca AB Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
MY148538A (en) 2005-06-22 2013-04-30 Astrazeneca Ab Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
US20090047716A1 (en) * 2007-06-07 2009-02-19 Nurit Perlman Reduction processes for the preparation of ezetimibe
EP2414529A2 (en) 2009-04-01 2012-02-08 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
WO2011056895A1 (en) * 2009-11-03 2011-05-12 University Of Notre Dame Du Lac Ionic liquids comprising heteraromatic anions
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9670237B2 (en) 2011-09-22 2017-06-06 Ut-Battelle, Llc Phosphonium-based ionic liquids and their use in the capture of polluting gases
WO2015048765A1 (en) 2013-09-30 2015-04-02 University Of Notre Dame Du Lac Compounds, complexes, compositions, methods and systems for heating and cooling
US10086331B2 (en) 2013-11-05 2018-10-02 University Of Notre Dame Du Lac Carbon dioxide capture using phase change ionic liquids
JP6803138B2 (ja) * 2014-10-22 2020-12-23 三星エスディアイ株式会社Samsung SDI Co., Ltd. ホスホニウム系化合物、それを含むエポキシ樹脂組成物、およびそれを用いて製造された半導体装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2107548T3 (es) * 1991-07-23 1997-12-01 Schering Corp Compuestos de beta-lactama sustituidos utiles como agentes hipocolesterolemicos y procedimientos para su preparacion.
FI960095L (fi) * 1993-07-09 1996-01-09 Schering Corp Menetelmä atsetidinonien syntetitoimiseksi
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
HRP20030498A2 (en) * 2000-12-21 2005-04-30 Aventis Pharma Deutschland Gmbh Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same

Also Published As

Publication number Publication date
DE502005001841D1 (de) 2007-12-13
EP1756049A1 (de) 2007-02-28
KR20070027554A (ko) 2007-03-09
AR049184A1 (es) 2006-07-05
BRPI0510150A (pt) 2007-10-02
US20070149776A1 (en) 2007-06-28
TW200611896A (en) 2006-04-16
IL178991A0 (en) 2007-03-08
NZ551413A (en) 2009-07-31
MA28635B1 (fr) 2007-06-01
PT1756049E (pt) 2007-12-17
MXPA06013456A (es) 2007-03-01
WO2005113496A1 (de) 2005-12-01
US7488818B2 (en) 2009-02-10
JP2007538042A (ja) 2007-12-27
PL1756049T3 (pl) 2008-02-29
RU2380361C2 (ru) 2010-01-27
CA2567149A1 (en) 2005-12-01
RS50539B (sr) 2010-05-07
AU2005245124A1 (en) 2005-12-01
RU2006145444A (ru) 2008-06-27
ES2294712T3 (es) 2008-04-01
EP1756049B1 (de) 2007-10-31
DK1756049T3 (da) 2008-02-25
HRP20070570T3 (en) 2008-01-31
ATE376997T1 (de) 2007-11-15
UY28912A1 (es) 2005-12-30
HK1103296A1 (zh) 2007-12-14

Similar Documents

Publication Publication Date Title
CY1107425T1 (el) Μεθοδος για την παρασκευη παραγωγων 1,4-διφαινυλαζετιδινονης
CY1110956T1 (el) Παραγωγα πυριδο-πυραζινης χρησιμα ως ζιζανιοκτονες ενωσεις
CY1125220T1 (el) Αμιδο-υποκατεστημενες ετεροκυκλικες ενωσεις χρησιμες ως διαμορφωτες των αποκρισεων il-12, il- 23 και/ή ifn αλφα
CY1123866T1 (el) Οπτοηλεκτρονικη διαταξη
CY1124798T1 (el) Υποκατεστημενα παραγωγα καρβονουκλεοζιδιων χρησιμα ως παραγοντες κατα των καρκινων
CY1125004T1 (el) Ετεροαρυλο υποκατεστημενες βητα-υδροξυαιθυλαμινες για χρηση στη θεραπεια της υπεργλυκαιμιας
UA81567C2 (en) Heteroaroyl-substituted phenylalanine amides
TW200519106A (en) Organic compounds
NO20061656L (no) 2,4 di(hetero)-arylamino-pyrimidin derivaer som ZAP-70 og/aller SYK inhibitorer
EA201990846A1 (ru) СОЕДИНЕНИЯ БЕНЗО[b]ТИОФЕНА КАК АГОНИСТЫ STING
CY1111544T1 (el) Παραγωγα πυραζολοπυριδινης
EA201000558A1 (ru) Производные имидазола
CY1111166T1 (el) Νεα παραγωγα 1,4-βενζοθειεπινο-1,1-διοξειδιου υποκατεστημενα με ριζες βενζυλιου, μεθοδοι διεργασιων για την παρασκευη τους, φαρμακα που περιεχουν αυτες τις ενωσεις και η χρηση τους
CY1116207T1 (el) Ινδαζολιο, βενζοξαζολιο και πυραζολοπυριδινο παραγωγα ως αναστολεις της ρ38 κινασης
EA201000549A1 (ru) Производные пиперидина и пиперазина
TW200517386A (en) Organic compounds
TW200714589A (en) Phenylacetamides suitable as protein kinase inhibitors
ATE449069T1 (de) Aminopropanolderivate
UA113412C2 (xx) 3-алкокси, тіоалкіл і аміно-4-аміно-6-(заміщені) піколінати та їхнє застосування як гербіцидів
EA201300283A1 (ru) Производные фуропиридина
CY1110457T1 (el) Παραγωγα της πυριδο[2,3-d]πυριμιδινης, η παρασκευη τους και η εφαρμογη τους σε θεραπευτικες αγωγες
BR0310055A (pt) Derivados de piridinacarboxamida pesticidas
BRPI0416690A (pt) derivados de pirrol
TN2009000267A1 (en) 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
MX2019001608A (es) Tratamiento de tumores y linfomas no de hodgkin solidos, reincididos y/o refractarios.